Agranulocytosis
7
0
0
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 7 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (7)
Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin
Clozapine Hematological Monitoring Regulatory Compliance Assessment in Psychiatry
Natural History Study for BEN
Evaluation of Reporting of Antibody-Drug Conjugate Associated Sepsis-related Toxicities
Etiology of Blood Dyscrasias: Analysis of the International Agranulocytosis and Aplastic Anemia Study Data
Drug Etiology of Aplastic Anemia and Related Dyscrasias
Genetic Study of Antithyroid Drugs Associated Agranulocytosis